Prospective Observational Study of Filgotinib in Subjects With Rheumatoid Arthritis
NCT ID: NCT04871919
Last Updated: 2025-09-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
1304 participants
OBSERVATIONAL
2021-05-11
2028-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Observational Study of Filgotinib in Participants With Rheumatoid Arthritis in France
NCT05323591
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
NCT03025308
Filgotinib Versus Placebo in Adults With Active Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Biologic Disease-modifying Anti-rheumatic Drug(s) (DMARDs) Treatment
NCT02873936
A Study Evaluating the Effect of Filgotinib in Participants With Active Axial Spondyloarthritis
NCT05785611
Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
NCT02889796
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Filgotinib
Individuals will receive treatment for moderate to severe active rheumatoid arthritis with at least one dose of filgotinib in accordance with the product label
Filgotinib
Tablets are administered in accordance with the product label
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Filgotinib
Tablets are administered in accordance with the product label
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients must be willing and able to use an electronic device to complete the study patient-reported outcome (PRO).
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alfasigma S.p.A.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alfasigma Study Director
Role: STUDY_DIRECTOR
Alfasigma S.p.A.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sint Maartenskliniek
Ubbergen, , Netherlands
Complexo Hospitalario Universitario
A Coruña, , Spain
Hospital del Mar
Barcelona, , Spain
Hospital Universitario Vall d'Hebrón
Barcelona, , Spain
C.H. Regional Reina Sofia
Córdoba, , Spain
Hospital de Mérida
Mérida, , Spain
Hospital Universitario Virgen de La Arrixaca
Murcia, , Spain
Hospital Universitari Son Espases
Palma, , Spain
Hospital Provincial de Pontevedra
Pontevedra, , Spain
Hospital Universitario Hospiten Rambla de Tenerife
Santa Cruz de Tenerife, , Spain
Algemeen Stedelijk Ziekenhuis
Aalst, , Belgium
Imelda VZW
Bonheiden, , Belgium
AZ Sint-Jan Brugge-Oostende
Bruges, , Belgium
Hôpital Erasme
Brussels, , Belgium
Cliniques Universitaires Saint-Luc
Brussels, , Belgium
Grand Hôpital de Charleroi asbl
Charleroi, , Belgium
UZ Antwerpen
Edegem, , Belgium
Reumacentrum Genk
Genk, , Belgium
Reumaclinic Genk
Genk, , Belgium
AZ Maria Middelares
Ghent, , Belgium
Reuma Instituut
Hasselt, , Belgium
UZ Leuven
Leuven, , Belgium
CHU de Liège
Liège, , Belgium
ZNA Jan Palfijn
Merksem, , Belgium
CHU UCL Namur asbl - Site Godinne
Yvoir, , Belgium
Rheumazentrum Kupka
Altenburg, , Germany
Praxis für Rheumatologie - Amberg
Amberg, , Germany
Rheumatology Center Prof. Neeck
Bad Doberan, , Germany
Charité Campus Mitte, Klinik für Rheumatologie und Klinische Immunologie
Berlin, , Germany
Rheumatologische Schwerpunktpraxis
Berlin, , Germany
Rheumapraxis am Schlachtensee
Berlin, , Germany
Rheumapraxis Mexikoplatz
Berlin, , Germany
Klinik fur Innere Medizin - Rheumatologie - Kreiskrankenhaus Demmin
Demmin, , Germany
Rheumatologisches MVZ Dresden
Dresden, , Germany
Universitatsklinikum Dusseldorf
Düsseldorf, , Germany
Praxis Dilltal
Ehringshausen, , Germany
MVZ Ambulantes Rheumazentrum Erfurt
Erfurt, , Germany
Universitätsmedizin Greifswald, Abteilung Innere Medizin A
Greifswald, , Germany
Internistisch-Rheumatologische Arztpraxis
Halle, , Germany
Rheumatologie im Struenseehaus
Hamburg, , Germany
Praxis für Rheumatologie
Hamburg, , Germany
Rheumazentrum Ruhrgebiet
Herne, , Germany
Rheumapraxis
Leipzig, , Germany
Praxis für Internistische Rheumatologie
Leipzig, , Germany
Rheumatologische Facharztpraxis
Magdeburg, , Germany
Rheumapraxis
Mansfeld, , Germany
Praxis far Rheumatologie, Gastroenterologie und Innere Medizin
München, , Germany
Rheumatologisches Praxiszentrum St. Bonifatius
München, , Germany
Rheumapraxis
Neubrandenburg, , Germany
Medizinischen Versorgungszentrums für Rheumatologie
Planegg, , Germany
Rheumahaus - GbR
Potsdam, , Germany
Rheumazentrum Ratingen
Ratingen, , Germany
Rheumatologisch-immunologische Arztpraxis
Templin, , Germany
Krankenhaus der Barmherzigen Brüder
Trier, , Germany
Klinikverbund St. Antonius und St. Josef GmbH
Wuppertal, , Germany
A.O.U. Policlinico di Bari
Bari, , Italy
ASST degli Spedali Civili di Brescia
Brescia, , Italy
AOU Policlinico Vittorio Emanuele-PO San Marco
Catania, , Italy
A.O.U. di Ferrara - Nuovo ospedale S.Anna
Ferrara, , Italy
S.C. Reumatologia Asl3
Genova, , Italy
ASST Gaetano Pini CTO
Milan, , Italy
Azienda Osp. Univ. Luigi Vanvitelli
Napoli, , Italy
Policlinico Umberto I Univ. Sapienza
Roma, , Italy
Policlinico Gemelli
Roma, , Italy
Azienda Ospedaliera Universitaria Integrata Di Verona
Verona, , Italy
Noordwest Ziekenhuisgroep
Alkmaar, , Netherlands
READE
Amsterdam, , Netherlands
Medisch Spectrum Twente
Enschede, , Netherlands
Reumazorg Zuid West
Goes, , Netherlands
Elkerliek Ziekenhuis
Helmond, , Netherlands
Medisch Centrum Leeuwarden
Leeuwarden, , Netherlands
Erasmus MC
Rotterdam, , Netherlands
Hagaziekenhuis
The Hague, , Netherlands
Hospital Clinico Universitario
Santiago de Compostela, , Spain
Hospital Universitario Virgen Macarena
Seville, , Spain
Hospital Universitario Virgen del Rocio - PPDS
Seville, , Spain
Aberdeen Royal Infirmary PPDS
Aberdeen, , United Kingdom
Royal Free NHS Foundation Trust
Barnet, , United Kingdom
University Hospital Coventry
Coventry, , United Kingdom
Doncaster Royal Infirmary
Doncaster, , United Kingdom
Ninewells Hospital - PPDS
Dundee, , United Kingdom
Western General Hospital Edinburgh - PPDS
Edinburgh, , United Kingdom
Royal Liverpool University Hospital
Liverpool, , United Kingdom
Guy's and St Thomas NHS Foundation Trust - Guy's Hospital
London, , United Kingdom
Kings College Hospital
London, , United Kingdom
Luton and Dunstable Hospital
Luton, , United Kingdom
Freeman Hospital
Newcastle, , United Kingdom
Royal Berkshire Hospital NHS Foundation Trust
Reading, , United Kingdom
York Teaching Hospitals NHS Foundation Trust
York, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
48323
Identifier Type: OTHER
Identifier Source: secondary_id
GLPG0634-CL-401
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.